As of 2025-06-12, the Relative Valuation of ProQR Therapeutics NV (PRQR) is - USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of ProQR Therapeutics NV based on Relative Valuation is -.
The range of the Relative Valuation is - USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-06-06 | -5.84 |
| 2025-06-05 | -5.48 |
| 2025-06-04 | -5.54 |
| 2025-06-03 | -5.44 |
| 2025-06-02 | -5.44 |
| 2025-05-30 | -5.08 |
| 2025-05-29 | -5.32 |
| 2025-05-28 | -5.20 |
| 2025-05-27 | -5.20 |
| 2025-05-23 | -5.11 |
| 2025-05-22 | -5.17 |
| 2025-05-21 | -5.26 |
| 2025-05-20 | -5.38 |
| 2025-05-19 | -5.23 |
| 2025-05-16 | -4.96 |
| 2025-05-15 | -4.99 |
| 2025-05-14 | -4.74 |
| 2025-05-13 | -4.68 |
| 2025-05-12 | -4.86 |
| 2025-05-09 | -4.92 |
| 2025-05-08 | -4.74 |
| 2025-05-07 | -4.80 |
| 2025-05-06 | -4.77 |
| 2025-05-05 | -5.51 |
| 2025-05-02 | -6.09 |
| 2025-05-01 | -5.26 |
| 2025-04-30 | -5.08 |
| 2025-04-29 | -4.99 |
| 2025-04-28 | -4.71 |
| 2025-04-25 | -4.37 |
| 2025-04-24 | -4.71 |
| 2025-04-23 | -4.44 |
| 2025-04-22 | -4.13 |
| 2025-04-21 | -4.04 |
| 2025-04-17 | -3.49 |
| 2025-04-16 | -3.49 |
| 2025-04-15 | -3.64 |
| 2025-04-14 | -3.61 |
| 2025-04-11 | -3.43 |
| 2025-04-10 | -3.46 |
| 2025-04-09 | -3.67 |
| 2025-04-08 | -3.46 |
| 2025-04-07 | -3.58 |
| 2025-04-04 | -3.61 |
| 2025-04-03 | -3.88 |
| 2025-04-02 | -4.19 |
| 2025-04-01 | -3.95 |
| 2025-03-31 | -4.07 |
| 2025-03-28 | -4.28 |
| 2025-03-27 | -4.37 |